ALPMY
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)
$47
About ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Details
Daily high
$13.56
Daily low
$13.45
Price at open
$13.56
52 Week High
$17.35
52 Week Low
$9.11
Market cap
24.1B
Dividend yield
3.68%
Volume
380,310
Avg. volume
221,572
P/E ratio
12.42
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. News
Details
Daily high
$13.56
Daily low
$13.45
Price at open
$13.56
52 Week High
$17.35
52 Week Low
$9.11
Market cap
24.1B
Dividend yield
3.68%
Volume
380,310
Avg. volume
221,572
P/E ratio
12.42